Latin America Gene Expression Market Report and Forecast 2024-2032

Latin America Gene Expression Market Size

The global gene expression market  was valued at USD 13.3 billion in 2023, with Latin America holding a significant market share. The market is driven by the growing emphasis on genomics research. It is expected to grow at a CAGR of 10.42% during the forecast period of 2024-2032, with the values likely to attain USD 32.4 billion by 2032.

Latin America Gene Expression Market Outlook

• In December 2023 , a cross-sectional survey published in the Lancet reported that respondents in Uruguay had the highest levels of self-reported chronic diseases, accounting for 43.2% of the cases. The rising burden of chronic diseases is expected to drive the market demand in the region.

• One of the major Latin America gene expression market trends is the increased strategic partnerships among the key market players to improve access to advanced genomic technologies. In May 2023, Pfizer, and Thermo Fisher Scientific Inc.,  entered into a collaboration agreement to boost local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in over 30 countries including Latin America.

• In April 2022, Illumina Inc ., announced the launch of a new Solution Center in Brazil, to address the increasing demand for clinical genomics. Such rapid expansion of genomic testing and gene expression analysis capabilities is anticipated to elevate the market value.

Latin America Gene Expression Market Analysis

The market offers products and services used to study and analyze gene expression including devices for extracting genetic material, amplifying DNA or RNA, and analyzing gene expression patterns. The rising technological advancements leading to enhanced speed, accuracy, and affordability of gene expression analysis coupled with the growing demand for personalized treatment approaches are expected to drive the Latin America gene expression market growth.

Latin America is experiencing a high burden of chronic diseases such as cancer, diabetes, and cardiovascular diseases. In December 2023 , a cross-sectional survey of 4 Latin American countries (Colombia, Mexico, Peru, and Uruguay) published in the Lancet reported that respondents in Uruguay had the highest levels of self-reported chronic diseases, accounting for 43.2% of the cases as compared with approximately 25% in the three other countries. Since gene expression studies are integral for understanding these diseases and developing advanced diagnostic and therapeutic strategies, the Latin America gene expression market demand is expected to witness a surge.

One of the major market trends is the increased strategic partnerships among the key market players to improve access to advanced genomic technologies and impact patient outcomes. For instance, in May 2023, Pfizer and Thermo Fisher Scientific Inc.,  entered into a collaboration agreement to boost local access to next-generation sequencing  (NGS)-based testing for lung and breast cancer patients in over 30 countries including Latin America. This rising availability and adoption of next-generation sequencing technologies are likely to augment the demand for gene expression analysis tools and technologies, thereby propelling market growth.

The Latin America gene expression market share is also influenced by the growing emphasis on genomics research supported by substantial investments from both the public and private sectors. In April 2022, Illumina Inc ., announced the launch of a new regional Solution Center in São Paulo, Brazil, to address the increasing demand and interest for clinical genomics in Latin America. Such rapid expansion of genomic testing and gene expression analysis capabilities is anticipated to elevate the market value.

Latin America Gene Expression Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Leading Players in the Latin America Gene Expression Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• PerkinElmer

• Illumina, Inc.

• Oxford Gene Technology (OGT) Group

• Luminex Corporation

• QIAGEN

• Affymetrix

• Life Technologies

• Agilent Technologies

• Bio-Rad Laboratories

• GE Healthcare

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report